Pd29-12 the Impact of the Time Elapsed Between Primary Treatment and BCR on Cancer Specific Mortality in Patients Who Experienced BCR After Primary Treatment

You have accessJournal of UrologyProstate Cancer: Epidemiology we can see that this strongly varied according to time to BCR. For instance, patients with intermediate-risk cancer who experienced BCR >3yr after RP had a cancer specific survival probability at 10yr after BCR>95%. CONCLUSIONS: Time to BCR is significantly associated with CSM. This information should be considered to stratify patients with BCR. Oncological follow-up after primary treatment could be safely discontinued after a long follow-up for low and intermediated risk patients given their low risk of CSM. Download PPT Source of Funding: No © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e623 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Francesco Pellegrino More articles by this author Ugo G. Falagario More articles by this author Ahmad Abbadi More articles by this author Lars Björnebo More articles by this author Alexander Valdman More articles by this author Giuseppe Carrieri More articles by this author Alberto Briganti More articles by this author Francesco Montorsi More articles by this author Olof Akre More articles by this author Markus Aly More articles by this author Martin Eklund More articles by this author Tobias Nordström More articles by this author Henrik Grönberg More articles by this author Anna Lantz More articles by this author Peter Wiklund More articles by this author Expand All Advertisement PDF downloadLoading ...